Department of Pathology, Leiden University Medical Center, Leiden, The Netherlands.
Department of Pathology, Leiden University Medical Center, Leiden, The Netherlands.
Kidney Int. 2019 Sep;96(3):738-749. doi: 10.1016/j.kint.2019.04.028. Epub 2019 May 16.
Recent studies suggest that complement plays a role in the pathogenesis of focal segmental glomerulosclerosis (FSGS). Moreover, co-localization of IgM and C3 deposits with FSGS lesions has frequently been reported. Here, we investigated whether glomerular complement deposition precedes the development of FSGS and whether it represents local complement activation. Renal biopsies from 40 patients with primary FSGS, 84 patients with minimal change disease, and 10 healthy individuals were stained for C4d, C1q, and mannose-binding lectin. C4d deposits were also measured in renal allograft biopsies from 34 patients with native primary FSGS, 18 of whom subsequently developed recurrent FSGS. Lastly, we measured C4d deposits in the Munich Wistar Frömter rat model of FSGS. The prevalence of C4d-positive glomeruli was significantly higher among patients with FSGS (73%) compared to patients with minimal change disease (21%) and healthy individuals (10%). Moreover, segmental sclerosis was absent in 42% of C4d-positive glomeruli. Glomerular C1q was significantly more prevalent in FSGS compared to minimal change disease or healthy individuals, while mannose-binding lectin was infrequently observed. C4d deposition was significantly more prevalent in recurrent FSGS (72%) before the development of sclerotic lesions compared to control transplant samples (27%). Finally, at the onset of albuminuria but before the development of FSGS lesions, Munich Wistar Frömter rats had a significantly higher percentage of C4d-positive glomeruli (31%) compared to control rats (4%). Thus, glomerular C4d deposition can precede the development of FSGS, suggesting that complement activation may play a pathogenic role in the development of FSGS.
最近的研究表明,补体在局灶节段性肾小球硬化症(FSGS)的发病机制中起作用。此外,IgM 和 C3 沉积物与 FSGS 病变的共定位经常被报道。在这里,我们研究了肾小球补体沉积是否先于 FSGS 的发生,以及它是否代表局部补体激活。对 40 例原发性 FSGS 患者、84 例微小病变性肾病患者和 10 例健康个体的肾活检进行了 C4d、C1q 和甘露聚糖结合凝集素染色。还在 34 例原发性 FSGS 患者的肾移植活检中测量了 C4d 沉积物,其中 18 例随后发展为复发性 FSGS。最后,我们在 FSGS 的慕尼黑威斯特伐利亚 Frömter 大鼠模型中测量了 C4d 沉积物。FSGS 患者中 C4d 阳性肾小球的患病率明显高于微小病变性肾病患者(21%)和健康个体(10%)(73%)。此外,在 42%的 C4d 阳性肾小球中没有节段性硬化。与微小病变性肾病或健康个体相比,FSGS 中肾小球 C1q 的患病率明显更高,而甘露聚糖结合凝集素则很少观察到。与对照移植样本(27%)相比,在发生硬化病变之前,复发性 FSGS(72%)中 C4d 沉积的患病率明显更高。最后,在出现蛋白尿但尚未发生 FSGS 病变之前,慕尼黑威斯特伐利亚 Frömter 大鼠的 C4d 阳性肾小球比例(31%)明显高于对照大鼠(4%)。因此,肾小球 C4d 沉积可先于 FSGS 的发生,表明补体激活可能在 FSGS 的发生中起致病作用。